Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CHINA BIOPHARMA, INC. (CBPC)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-08Dec-31-07Dec-31-06Dec-31-05
   10-K10-K10-K/A10-K/A
Revenues:  
    United States     0.2
    Other     0.1
Revenues  5.50.71.20.4
            Revenue growth  704.6%-42.7%216.1% 
Cost of goods sold  5.30.61.10.2
Gross profit  0.20.10.10.2
            Gross margin  3.8%10.7%10.6%53.5%
Selling, general and administrative  0.71.43.82.2
EBITDA   [+]-0.9-1.3-3.7-2.6
            EBITDA margin  -17.1%-189.7%-303.8%-682.7%
Depreciation and amortization  0.00.00.00.1
EBIT   [+]-1.0-1.3-3.7-2.7
            EBIT margin  -17.4%-195.8%-304.6%-718.4%
Non-recurring items   [+] 0.3  
Interest expense, net   [+]0.10.2 0.0
Other income (expense), net  0.10.1-1.1-0.1
Pre-tax income  -0.9-1.8-4.7-2.8
Income taxes  0.0-0.10.00.0
            Tax rate   6.0%0.0%0.0%
Minority interest  0.0-0.1  
Net income  -0.9-1.7-4.7-2.8
            Net margin  -16.8%-240.0%-392.9%-746.7%
   
Basic EPS   [+]($0.22)($1.48)($0.06)($0.03)
Diluted EPS   [+]($0.22)($1.48)($0.06)($0.03)
   
Shares outstanding (basic)   [+]4.21.185.581.5
Shares outstanding (diluted)   [+]4.21.185.581.5
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy